Replies to post #183073 on Innovation Pharmaceuticals Inc (IPIX)

[MinnieM]

Instead of one large and expensive phIII we now have three drugs in four phII's. I like that better due to the de risking instead of all riding on one trial.

In addition to de risking, this strategy is showing potential value of pipeline to be higher.






In Reply to 'scottsmith'
That was also when everyone assumed absssi would be close to a year into the phase 3.